Shamkhalova, M. S., & Sukhareva, O. Y. Early intensification of therapy for type 2 diabetes mellitus and achievement of the target level of glycohemoglobin HbA<sub>1c</sub> are necessary factors to reduce the risk of micro- and macrovascular complications. Endocrinology Research Centre.
Chicago Style (17th ed.) CitationShamkhalova, M. S., and O. Y. Sukhareva. Early Intensification of Therapy for Type 2 Diabetes Mellitus and Achievement of the Target Level of Glycohemoglobin HbA<sub>1c</sub> Are Necessary Factors to Reduce the Risk of Micro- and Macrovascular Complications. Endocrinology Research Centre.
MLA (9th ed.) CitationShamkhalova, M. S., and O. Y. Sukhareva. Early Intensification of Therapy for Type 2 Diabetes Mellitus and Achievement of the Target Level of Glycohemoglobin HbA<sub>1c</sub> Are Necessary Factors to Reduce the Risk of Micro- and Macrovascular Complications. Endocrinology Research Centre.